Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Methodologic shortcomings inherent in a post-hoc analysis.

× No keyword cloud information.

6 in total

1. Medical treatment of overactive bladder.

Authors: R Rackley; A Wein; D Nelson
Journal: Mayo Clin Proc Date: 2001-11 Impact factor: 7.616

2. Sponsorship, authorship, and accountability.

Authors: F Davidoff; C D DeAngelis; J M Drazen; M G Nicholls; J Hoey; L Højgaard; R Horton; S Kotzin; M Nylenna; A J Overbeke; H C Sox; M B Van Der Weyden; M S Wilkes
Journal: N Engl J Med Date: 2001-09-13 Impact factor: 91.245

3. Tolterodine--a new bladder-selective antimuscarinic agent.

Authors: L Nilvebrant; K E Andersson; P G Gillberg; M Stahl; B Sparf
Journal: Eur J Pharmacol Date: 1997-05-30 Impact factor: 4.432

4. Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.

Authors: R A Appell; P Sand; R Dmochowski; R Anderson; N Zinner; D Lama; M Roach; J Miklos; D Saltzstein; T Boone; D R Staskin; D Albrecht
Journal: Mayo Clin Proc Date: 2001-04 Impact factor: 7.616

Review 5. Principles of clinical trial design.

Authors: S Piantadosi
Journal: Semin Oncol Date: 1988-10 Impact factor: 4.929

6. Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder.

Authors: P Van Kerrebroeck; K Kreder; U Jonas; N Zinner; A Wein
Journal: Urology Date: 2001-03 Impact factor: 2.649

6 in total

1 in total

Review 1. Pharmacological management of overactive bladder : a systematic and critical review of published economic evaluations.

Authors: Denis Getsios; Wissam El-Hadi; Ingrid Caro; J Jaime Caro
Journal: Pharmacoeconomics Date: 2005 Impact factor: 4.981

1 in total